Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concomitant Stamaril and CYD Dengue Vaccine in Toddlers
NCT01436396Phase 3Completed
- Sponsor
- Sanofi
- Start
- Sep 2011
- Primary completion
- Sep 2013
- Modality
- Live Attenuated Vaccines, Recombinant Vaccines
- Countries
- 2
01
Overview
A Phase 3 trial of Cyd dengue virus serotype 1 live (attenuated) antigen in dengue fever, sponsored by Sanofi. Started Sep 2011; status: completed.
02
Drugs
Cyd dengue virus serotype 1 live (attenuated) antigen
03
Conditions
dengue fever
Beyond the preview
Go deeper on NCT01436396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01436396.